Singapore has begun the first phase of a broad transfer of healthcare regulation from the Ministry of Health’s Health Regulation Group to the Health Sciences Authority.
From November 1, the authority administers licensing and approvals under the Healthcare Services Act, notifications and approvals under the Human Biomedical Research Act, and facility registrations under the Biological Agents and Toxins Act. It also assumes specified cybersecurity, data-security and National Electronic Health Record functions under the Health Information Act.
The transfer includes regulatory work involving healthcare charities and institutions of a public character. It brings service licensing, research oversight, biological-agent controls and selected information-governance duties into an agency that already regulates health products, laboratories and other scientific functions.
Existing licences and approvals remain valid. Providers are not required to reapply simply because responsibility has moved between public bodies. Digital transactions previously handled through the Healthcare Application and Licensing Portal will continue under the authority’s administration, and regulated entities should direct new filings and compliance questions to the channels identified for the transferred function.
The change is institutional rather than a release from substantive obligations. Licence conditions, reporting duties and enforcement exposure continue under the governing Acts. Later phases may move additional functions, but they should not be treated as part of the November 1 transfer until their commencement is formally confirmed.
The Health Sciences Authority has published an official guide to the integrated healthcare regulatory system.
